July 13th 2010ArticleNews
Weikang Bio-Technology Group, a Chinese manufacturer and marketer of traditional Chinese medicines, is launching a new project to research and develop liquorice flavonoids for use in therapeutics. For the study, the company reports that it intends to use supercritical carbon dioxide extraction technology to produce superior quality herbal extracts, column chromatography to isolate and purify compounds and HPLC to separate, identify and quantify compounds based on their idiosyncratic polarities.